Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about INCY

Recent news which mentions INCY

< Previous 1 2 3 4 5 6 Next >
Expert Ratings for Incyte
Tickers INCY
Tags BZI/AAR Analyst Ratings Benzinga
From Benzinga
3 Biotech Stocks That Should Be on Every Investor’s Radar This Fall
Tickers EXEL INCY JAZZ
Tags NASDAQ:JAZZ,NASDAQ:INCY,NASDAQ:EXEL Stocks to Buy EXEL
From InvestorPlace
Anemia Advantage For GSK's Blood Cancer Therapy Could Influence Market Share Despite Incyte's Jakafi Comparison
Tickers BMY GSK INCY
Tags Markets Expert Ideas INCY
From Benzinga
Analyst Ratings for Incyte
Tickers INCY
Tags INCY Market News BZI/AAR
From Benzinga
Incyte's Jakafi Patent Expiry In 2028 Poses Challenge, Analyst Says New Treatments To Battle For Market Share
Tickers INCY
Tags Benzinga Briefs News
From Benzinga
Incyte's Earnings Outlook
Tickers INCY
Tags Benzinga Earnings BZI/EP
From Benzinga
Cathie Wood's Ark Invest Buys Spotify, Iridium Shares — Trims Tesla, Coinbase Holdings
Tickers ACCD AIR ARKQ ARKW
Tags TSLA News Spotify
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 25, 2023
Tickers ABBV AGLE AI AVNS
Tags DIS CTVA TITN
From Benzinga
Syndax-Incyte Partnered Chronic Graft-Versus-Host Disease Achieves Primary Endpoint In Pivotal Trial, FDA Submission Planned By 2023 End
Tickers INCY SNDX
Tags SNDX Small Cap Biotech
From Benzinga
'I Don't Want You To Touch That': Cramer Rejects Stock Down 32% Over Past Month, Prefers Tesla
Tickers ARE ASTS CNC FRT
Tags ASTS HUM Trading Ideas
From Benzinga
Incyte Skin Disease Drug Meets Primary Goal In Late-Stage Study In Children
Tickers INCY
Tags INCY Health Care Biotech
From Benzinga
Syndax Pharmaceuticals Set for Potential Breakthrough with Revumenib: Analyst Calls It 'Potentially Best-In-Class' In Competitive Landscape
Tickers INCY SNDX
Tags Expert Ideas INCY Health Care
From Benzinga
2 Low-Priced Stocks That Could Make You Richer
Tickers ACRS AGEN AXSM BMY
Tags MRK AXSM BMY
From Motley Fool
The bull market has left these 20 companies behind, but they are primed for growth
Tickers AAPL AMZN BLK CI
Tags SPY GOOGL HES
From MarketWatch
Benzinga's Top Ratings Upgrades, Downgrades For May 4, 2023
Tickers ABSI BLDR BLKB CERE
Tags PCOR HT SPR
From Benzinga
Why Incyte Shares Are Falling Today
Tickers INCY
Tags why it's moving INCY Guidance
From Benzinga
Earnings Outlook For Incyte
Tickers INCY
Tags INCY Market News Benzinga
From Benzinga
What To Expect When Incyte Reports Q1 Earnings In Almost Two Weeks
Tickers CTIC INCY
Tags Biotech Market News Small Cap
From Benzinga
7 Biotech Stocks That Could Cure Your Portfolio Woes
Tickers ARGX BGNE BMRN INCY
Tags Market News NASDAQ:BGNE,NASDAQ:INCY,NASDAQ:BMRN,NASDAQ:ARGX,NASDAQ:UTHR,NASDAQ:TECH,NASDAQ:LEGN BMRN
From InvestorPlace
Ominous Death Cross Forms On Incyte's Chart
Tickers INCY
Tags Trading Ideas BZI/CROSS Benzinga
From Benzinga
Incyte Faces Increased Competition From Emerging JAK Inhibitors, RBC Capital Lowers Price Target
Tickers INCY
Tags Price Target Market News INCY
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For April 10, 2023
Tickers AMH AVB BBWI BCE
Tags GEHC AMH WU
From Benzinga
Valero Energy To Rally 32%? Here Are 10 Other Analyst Forecasts For Monday
Tickers BA CLNN CTLT CWK
Tags News Benzinga SQ
From Benzinga
What 13 Analyst Ratings Have To Say About Incyte
Tickers INCY
Tags BZI/AAR Analyst Ratings Benzinga
From Benzinga
Second Setback For Incyte's LIMBER Program - Analyst Says 'Resolution Timelines Unclear To Assess Impact'
Tickers INCY
Tags Biotech Market News Trading Ideas
From Benzinga
Incyte Would Now Compete With Merck, Pfizer As Its Skin Cancer Treatment Scores FDA Accelerated Approval
Tickers INCY MGNX MKGAF MKKGY
Tags MKGAF MGNX PFE
From Benzinga
7 Healthcare Stocks to Buy for Long-Term Growth and Stability
Tickers BIIB ESALY HRMY INCY
Tags INSP ESALY Stocks to Buy
From InvestorPlace
Why Shares of MacroGenics Climbed Thursday
Tickers INCY MGNX PRVB
Tags MGNX Recent Press Releases PRVB
From Motley Fool
Analyst Expectations for Incyte's Future
Tickers INCY
Tags Benzinga Analyst Ratings BZI/AAR
From Benzinga
Incyte Discontinues LIMBER-304 On Doubts Regarding Meeting Primary Goal, Analyst Says It Underpins Some Investor Concerns
Tickers INCY
Tags Briefs News Large Cap
From Benzinga
< Previous 1 2 3 4 5 6 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.